Therapeutic agent for ischemic diseases
US10993972B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Jan 18, 2016 |
| Grant date | May 4, 2021 |
| Priority date | — |
| Expiry date | Apr 5, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2871
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are: a transformation plasmid for transforming anaerobes and enabling highly efficient and stable secretory expression of a target protein; a gene delivery carrier formed from said anaerobes transformed by said plasmid; a pharmaceutical composition including said gene delivery carrier; and a method for diagnosing or treating an ischemic disease utilizing these. Also provided are: a novel secretory signal; a transformation plasmid including said secretory signal; a gene delivery carrier formed from anaerobes transformed by said plasmid; a pharmaceutical composition including said gene delivery carrier; and a method for diagnosing or treating an ischemic disease utilizing these.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.